Human NRSN2 ELISA Kit (V2LY-0626-LY4941)

Ren, S., Chen, M., Chen, Y., & Ding, K. (2023). NRSN2 is a Prognostic Biomarker in Gastric Cancer and Facilitates the Growth and Migration of Gastric Cancer Cells. Protein and Peptide Letters, 30(5), 427-438.

Wu, Y. B., Li, S. Y., Liu, J. Y., Xue, J. J., Xu, J. F., Chen, T., ... & Shen, C. (2023). Long non-coding RNA NRSN2-AS1 promotes ovarian cancer progression through targeting PTK2/β-catenin pathway. Cell Death & Disease, 14(10), 696.

Keremu, A., Aila, P., Tusun, A., Abulikemu, M., & Zou, X. (2022). Extracellular vesicles from bone mesenchymal stem cells transport microRNA-206 into osteosarcoma cells and target NRSN2 to block the ERK1/2-Bcl-xL signaling pathway. European Journal of Histochemistry: EJH, 66(3).

Chen, Q., Xie, J., & Yang, Y. (2022). Long non-coding RNA NRSN2-AS1 facilitates tumorigenesis and progression of ovarian cancer via miR-744-5p/PRKX axis. Biology of Reproduction, 106(3), 526-539.

Xu, T., Yan, Z., Lu, J., Chen, L., Li, X., Li, Y., ... & Guo, W. (2022). Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK1. Clinical & Experimental Metastasis, 39(5), 757-769.

Yan, Z., Xu, T., Lu, J., Wu, Z., Li, X., Xu, J., ... & Dong, Z. (2022). E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway. Pathology-Research and Practice, 236, 153963.

Li, F., Chen, X., Shang, C., Ying, Q., Zhou, X., Zhu, R., ... & Jiang, Z. (2021). Bone marrow mesenchymal stem cells-derived extracellular vesicles promote proliferation, invasion and migration of osteosarcoma cells via the lncRNA MALAT1/miR-143/NRSN2/Wnt/β-catenin axis. OncoTargets and therapy, 737-749.

Zhou, J., Xu, L., Yang, P., Lu, Y., Lin, S., & Yuan, G. (2021). The exosomal transfer of human bone marrow mesenchymal stem cell-derived miR-1913 inhibits osteosarcoma progression by targeting NRSN2. American Journal of Translational Research, 13(9), 10178.

Ren, F., Zhang, W., Lu, S., Ren, H., & Guo, Y. (2020). NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF‑κB signaling pathways. Oncology Letters, 19(1), 813-823.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols